International Workshop on
"Translational Research Strategies for Drug Discovery and Clinical Development"

Sponsor Details

TRANSCELL Oncologics

TranSTox Bioapplications offers human sourced biologic discards harvested primary stem cell based platforms as real time predictive tools mimicking clinical trials in the labs. These platforms can be used as alternatives to animal models and transformed cell lines in high throughput screening, discovery, hit to lead optimization, drug repurposing, pre-clinical testings qualifying for regulatory toxicity studies. The prediction covers: biocompatibility, target, functional efficacy, and safety profiles of simple to complex molecules that are being investigated or developed as drug candidates with apotential to support next-generation phenotype based drug discovery (PDD), which is believed to be forward pharmacology.